Eye (London, England) · 2024
Costs and cost-effectiveness of the Kerala pilot screening programme for diabetic retinopathy in the public health system.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wittenberg Raphael, Anderson Robert, Redding Stuart, Gopal Bipin, Sadanandan Rajeev, Sahasranamam Vasudeva Iyer, George Simon, Premnazir Lakshmi, Netuveli Gopalakrishnan, Srinath Jyotsna, Ramakrishnan Radha, Conroy Dolores, Sivaprasad Sobha
Аннотация
BACKGROUND/OBJECTIVES: The Government of Kerala initiated a pilot screening programme for diabetic retinopathy in 16 Family Health Centres in Thiruvananthapuram district in 2019 in collaboration with the ORNATE India project. The evaluation of this pilot included a study of its costs and cost-effectiveness to inform decisions about extending the programme throughout Kerala.
SUBJECTS/METHODS: The participants comprise all 5307 people who were screened for diabetic retinopathy under the pilot programme for whom data could be collected.
RESULTS: The costs of the pilot programme are estimated at INR 11.3 million (including INR 1.9 million costs to individuals) and the benefits at 514 QALYs, slightly over one QALY per person treated. The cost per QALY was INR 22,000, which is well below India's Gross National Income per person.
CONCLUSIONS: Kerala's 2019 pilot screening programme for diabetic retinopathy was highly cost-effective.
SUBJECTS/METHODS: The participants comprise all 5307 people who were screened for diabetic retinopathy under the pilot programme for whom data could be collected.
RESULTS: The costs of the pilot programme are estimated at INR 11.3 million (including INR 1.9 million costs to individuals) and the benefits at 514 QALYs, slightly over one QALY per person treated. The cost per QALY was INR 22,000, which is well below India's Gross National Income per person.
CONCLUSIONS: Kerala's 2019 pilot screening programme for diabetic retinopathy was highly cost-effective.